Semax 10mg vial

Neuropeptide

What is Semax?

Last updated: 29 October 2026

A synthetic ACTH fragment analogue studied in neuropeptide and BDNF-signalling research.

ACTH(4–7) analoguePreclinical research
Class
ACTH(4–7) analogue
Also known as
Met-Glu-His-Phe-Pro-Gly-Pro
Type
Heptapeptide
Research stage
Preclinical; regional clinical use outside the United States

01 · Classification

What it is

Semax is a seven-amino-acid peptide made of the ACTH(4–7) fragment joined to a Pro-Gly-Pro tail. The fragment has no hormonal (adrenal) activity, and the tail slows breakdown.

Like Selank, it was developed at the Institute of Molecular Genetics in Moscow.

02 · Mechanisms

What has been studied

  • BDNF and TrkB: studied for raising brain-derived neurotrophic factor expression in rodent brain tissue.
  • Melanocortin receptors: researched for possible interaction with MC4R and MC5R.
  • Ischaemia models: frequently studied in animal models of reduced blood flow to the brain.

03 · Evidence

Where the research is

Most published work is from Russian research groups. Independent controlled data is limited.

04 · Primary sources

Read the literature

Search the primary research record directly rather than relying on summaries, including this one.

Research use only

Supplied strictly for laboratory and educational research. Not a drug, not for human or veterinary use, and not evaluated by the FDA. This overview is not medical advice and gives no dosing or administration guidance.

← All research overviews